Although the precise molecular mechanism linking Spry1 to EMT needs further investigation, Spry1 expression appears to be critical for tumor induction, maintenance, and progression, and may potentially represent a novel vulnerability of CM harboring BRAF mutations. Here, BRAF is linked to neoplasm.